The Week In Review: Biotech Keeps July Rally Alive

July 31, 2005 -- In the summer of 2005, pundits do not have to wonder if the stock market will have a summer rally, because it has already had one and it has been a very nice rally, indeed, with the Centient Biotech 200™ up 372 points or 11% in July. For the last week, the CBT 200 was more than 31 points higher, adding on .85% and closing at 3735.02. Cerus led the way higher last week, detailing the mechanism of its new vaccine. New River hit a new all-time high, as did very recent IPO Adams Respiratory, which has been trading for just six sessions. Stem cells companies also rose, led by Lifecell which reported blockbuster earnings on its tissue repair product, a stock that has tripled over the last 4 months. More details...

Back to news